We are live on
!
Find out more
NA
NVP Associates Portfolio holdings
AUM
$176M
1-Year Est. Return
208.78%
This Fund
S&P 500
This Quarter
Est. Return
+44.35%
1 Year Est. Return
+208.78%
3 Year Est. Return
+867.48%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$395K
(+0.35%)
Cap. Flow
-$40.1M
Cap. Flow
% of AUM
-35.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UDMY
Udemy
UDMY
|
+$38.8M |
| 2 |
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
|
+$1.32M |
| 3 |
BRQS
Borqs Technologies, Inc. Ordinary Shares
BRQS
|
+$18.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 45.58% |
| 2 | Healthcare | 33.32% |
| 3 | Real Estate | 16.74% |
| 4 | Technology | 4.36% |
| 5 | Consumer Discretionary | 0% |
Similar funds
FF
USPCM
CWP
RAS
MFFIA
AF
DAM
XWL
NVP Associates's Q4 2023 Portfolio in Review
As of Q4 2023, NVP Associates held 8 positions worth $112M, up 0.35% from $112M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
NVP Associates withdrew a net $40.1M in Q4 2023, closing 2 positions and reducing 1 holding. Its most notable exit was Impel Pharmaceuticals Inc. Common Stock, an estimated $1.32M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 46% of assets, down from 60% a quarter earlier, followed by Healthcare and Real Estate.
- NVP Associates's biggest Q4 2023 reduction was Udemy, cutting an estimated $38.8M.
- NVP Associates fully exited Impel Pharmaceuticals Inc. Common Stock in Q4 2023, selling an estimated $1.32M.
- NVP Associates's ten largest holdings make up 100% of its $112M portfolio in Q4 2023.
- NVP Associates opened 0 new positions and closed 2 in Q4 2023.
- NVP Associates's portfolio value rose 0.35% quarter-over-quarter to $112M.
Based on NVP Associates's 13F filing for Q4 2023, filed 14 Feb 2024.